HeimEW • NYSE
add
Edwards Lifesciences Corp
Við síðustu lokun
86,82 $
Dagbil
86,55 $ - 87,40 $
Árabil
65,94 $ - 87,40 $
Markaðsvirði
49,12 ma. USD
Meðalmagn
4,93 m.
V/H-hlutf.
37,30
A/V-hlutfall
-
Aðalkauphöll
NYSE
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 1,55 ma. | 14,67% |
Rekstrarkostnaður | 782,80 m. | 12,28% |
Nettótekjur | 291,10 m. | -90,52% |
Hagnaðarhlutfall | 18,74 | -91,73% |
Hagnaður á hvern hlut | 0,67 | 0,00% |
EBITDA | 464,30 m. | 11,42% |
Virkt skatthlutfall | 16,10% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 3,84 ma. | -13,59% |
Heildareignir | 13,27 ma. | 2,32% |
Heildarskuldir | 3,07 ma. | -8,71% |
Eigið fé alls | 10,20 ma. | — |
Útistandandi hlutabréf | 580,30 m. | — |
Eiginfjárgengi | 4,94 | — |
Arðsemi eigna | 7,94% | — |
Ávöxtun eigin fjár | 9,57% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 291,10 m. | -90,52% |
Handbært fé frá rekstri | 573,70 m. | — |
Reiðufé frá fjárfestingum | -427,80 m. | — |
Reiðufé frá fjármögnun | -740,10 m. | — |
Breyting á handbæru fé | -595,20 m. | — |
Frjálst peningaflæði | 468,99 m. | — |
Um
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland. Wikipedia
Stofnsett
1958
Höfuðstöðvar
Vefsvæði
Starfsfólk
15.800
